1. 357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma. (9th November 2020) Authors: Collins, Sabrina; Joshi, Adarsh; Shen, Lei; Das, Subhasree; Suryanarayan, Kaveri; Bottino, Dean; Li, Cheryl; Curley, Michael; Wang, Dannie; Abadier, Michael; Larson, Ryan; Parot, Xavier Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 357 TAK-573, an anti-CD38–attenuated interferon alpha (IFNα) fusion protein (Attenukine™), has demonstrated IFNα receptor (IFNAR) pathway modulation in patients with relapsed/refractory multiple myeloma. (9th November 2020) Authors: Collins, Sabrina; Joshi, Adarsh; Shen, Lei; Das, Subhasree; Suryanarayan, Kaveri; Bottino, Dean; Li, Cheryl; Curley, Michael; Wang, Dannie; Abadier, Michael; Larson, Ryan; Parot, Xavier Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Infrarenal aortic clamp reviving a patient from acute surgical haemorrhagic shock: a novel management technique. (19th October 2016) Authors: Kumar, Ranjith; Satya Prakash, M V S; Das, Subhasree; Manikandan, Ramanitharan Journal: BMJ case reports Issue: Volume 2016 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗